THOROUGHBRED HORSES 
33 pages
Published: 5 Oct 2005
Author(s): Heuzenroeder, M., Barton, M, Vanniasinkam, T, Ph, T
Download report PDF
DownloadPurchase a hard copy - AUD $45.00
This publication describes further development of vaccines developed in earlier RIRDC grants and the testing of DNA and protein based vaccines against R. equi in non-equine models of infection. Good non-equine models of R. equi infection are essential for safety and efficacy testing prior to use in horses. 2005, 34pgs, Web Only, Pub No W05/158
The re-emergence of foot and mouth disease (FMD) in Indonesia in 2022 has emphasised the need for Australia to be prepared for a potential incursion....
In the wake of the 2022 foot and mouth disease (FMD) resurgence in Indonesia, there is a critical need for Australia to be prepared in...
The Australian thoroughbred breeding industry continues to grapple with managing risks related to Rhodococcus equi pneumonia, commonly known as ‘rattles’. The disease compromises foal health...
Infectious diseases can cause significant equine illness and death, seriously impacting the productivity of the Australian thoroughbred breeding industry and incurring economic losses. One well-known...
The Australian thoroughbred breeding industry is second in size only to that of the United States, with 660 stud farms predominantly in New South Wales,...
Equine herpes virus (EHV) is a DNA virus found in horses all around the world. There are different strains of EHV, with the most common...
Exposure to hairy processionary caterpillars (Ochrogaster lunifer), or their nest material, can damage tissues in the amnion, umbilical cord and placenta of developing fetuses, resulting...
Exposure to fetal material and bodily fluids poses a significant risk of spreading and contracting infectious diseases carried by pregnant mares. Monitor, test and suit-up...
